▮
Home
▮
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
IPOs
M&A
Canadian
UK
Key Wallstreet Events
▮
Industry News
Technology
Software
Banking
Automotive
Energy
More
▮
Stock Alerts
Active Traders
$5 and under
Intraday Updates
After the Bell
▮
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
▮
Earnings Calendars
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
▮
FDA Calendars
Drug Approvals
Device Approvals
Clinical Trial Calendar
▮
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
▮
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Fed Members
▮
Crypto
Cryptocurrency
Blockchain
▮
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
▮
Politics
US
World
White House
Elections
Congress
General News
▮
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
▮
Health
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
▮
Entertainment
Top Stories
Slide Shows
Game of Thrones
▮
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
▮
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
▮
Premium
NEW
Intelligent Investor
Emerging Biostocks
Under The Radar
Short-Term Investor
Login
▮
More
Free Content
RSS Feeds
Search
Contact Us
Home
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
IPOs
M&A
Canadian
UK
Key Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Stock Alerts
Active Traders
$5 and under
Intraday Updates
After the Bell
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendars
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Device Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Fed Members
Crypto
Cryptocurrency
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
Congress
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Entertainment
Top Stories
Slide Shows
Game of Thrones
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
NEW
Intelligent Investor
Emerging Biostocks
Under The Radar
Short-Term Investor
Login
More
Free Content
RSS Feeds
Search
Contact Us
Affimed N.V. (AFMD)
Trade AFMD now with
Date
Headline
2/1/2018 10:11:34 PM
AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva
Older Articles
Next